Results 31 to 40 of about 40,708 (270)

Critical evaluation of real-world evidence of repurposable medicines in the Alzheimer's disease drug development pipeline using a target trial emulation. [PDF]

open access: yesAlzheimers Dement (N Y)
Abstract INTRODUCTION Repurposing Food and Drug Administration (FDA)‐approved drugs could accelerate treatment development for Alzheimer's disease (AD). METHODS Using the MarketScan claims database (2011 to 2020), we applied a trial emulation approach in two base cohorts: (1) individuals with mild cognitive impairment (MCI cohort) and (2) individuals ...
Tonegawa-Kuji R   +10 more
europepmc   +2 more sources

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse

open access: yesAnnali dell'Istituto Superiore di Sanità, 2013
BACKGROUND AND OBJECTIVE: Despite animal studies having shown a generalisation of the bupropion cue to cocaine, this drug has been used in cocaine abuse with mixed results. We here aimed at describing two cases which contradict current knowledge.
Alessandro E. Vento   +6 more
doaj   +1 more source

Stereoselective method to quantify bupropion and its three major metabolites, hydroxybupropion, erythro-dihydrobupropion, and threo-dihydrobupropion using HPLC-MS/MS [PDF]

open access: yes, 2016
Bupropion metabolites formed via oxidation and reduction exhibit pharmacological activity, but little is known regarding their stereoselective disposition.
Desta, Zeruesenay   +3 more
core   +1 more source

Mechanisms of hepatocellular toxicity associated with new psychoactive synthetic cathinones [PDF]

open access: yes, 2017
Synthetic cathinones are a new class of psychostimulant substances. Rarely, they can cause liver injury but associated mechanisms are not completely elucidated.
Krähenbühl, Stephan   +2 more
core   +1 more source

Effectiveness of bupropion on sexual dysfunction of women with multiple sclerosis: A Clinical Trial [PDF]

open access: yesMajallah-i Zanān, Māmā̓ī va Nāzā̓ī-i Īrān, 2021
Introduction: Sexual dysfunctions are relatively prevalent in female patients with multiple sclerosis (MS) and affect their quality of life. This study was performed with aim to evaluate the effect of Bupropion on sexual function in women with multiple ...
Farzaneh Yavari   +7 more
doaj   +1 more source

Bupropion administration increases resting-state functional connectivity in dorso-medial prefrontal cortex [PDF]

open access: yes, 2017
Background: Patients on the selective serotonergic re-uptake inhibitors (SSRI) like citalopram report emotional blunting. We have shown previously that citalopram reduces resting-state functional connectivity (RSFC) in healthy volunteers in a number of ...
Dean, Zola   +2 more
core   +1 more source

Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose

open access: yesArchives of Epilepsy, 2018
Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack
Zeynep ÖZÖZEN AYAS   +1 more
doaj   +1 more source

Alcohol significantly lowers the seizure threshold in mice when co-administered with bupropion hydrochloride

open access: yesAnnals of General Psychiatry, 2008
Background Bupropion HCl is a widely used antidepressant that is known to cause seizures in a dose-dependent manner. Many patients taking antidepressants will consume alcohol, even when advised not to.
Fleming Rosanna   +4 more
doaj   +1 more source

General Practitioners' views on the provision of nicotine replacement therapy and bupropion. [PDF]

open access: yes, 2001
BACKGROUND: Nicotine replacement therapies (NRT) and a new drug, bupropion, are licensed in several countries as aids to smoking cessation. General practitioners (GPs) play a crucial role in recommending or prescribing these medications.
A McEwen   +21 more
core   +3 more sources

Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. [PDF]

open access: yes, 2020
BackgroundSmoking rates are high in adults with anxiety disorders (ADs), yet little is known about the safety and efficacy of smoking-cessation pharmacotherapies in this group.MethodsPost hoc analyses in 712 smokers with AD (posttraumatic stress disorder
Anthenelli, Robert M   +6 more
core  

Home - About - Disclaimer - Privacy